+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Genetic control of metabolism of mutagenic purine base analogs 6-hydroxylaminopurine and 2-amino-6-hydroxylaminopurine in yeast Saccharomyces cerevisiae



Genetic control of metabolism of mutagenic purine base analogs 6-hydroxylaminopurine and 2-amino-6-hydroxylaminopurine in yeast Saccharomyces cerevisiae



Genetika 45(4): 471-477



The influence of inactivation of genes, which control biosynthesis of inosine monophosphate (IMP) de novo and the purine utilization and interconversion pathway, on sensitivity of yeast Saccharomyces cerevisiae cells to the mutagenic and toxic action of 6-hydroxylaminopurine (HAP) and 2-amino-6-hydroxylaminopurine (AHA) was studied. It was shown that the manifestation of HAP and AHA mutagenic properties involves the action of enzyme adenine phosphoribosyltransferase encoded in yeast by APT1 gene. A blockade of each stage of IMP biosynthesis, with the exception of the block mediated by inactivation of genes ADE16 and ADE17 leading to the accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), was shown to enhance yeast cell sensitivity to the HAP mutagenic effect; however, it does not affect the sensitivity to AHA. A blockade of conversion of IMP into adenosine monophosphate (AMP) causes hypersensitivity of yeast cells to the mutagenic action of HAP and to the toxic effect of HAP, AHA, and hypoxanthine. It is fully probable that this enhancement of sensitivity to HAP and AHA is conditioned by changes in the pool of purines. This indicates that genes ADE12, ADE13, AAH1, and HAM1 controlling processes of purine utilization and interconversion in yeast make the greatest contribution to the system of protection against the toxic and mutagenic action of the examined analogs. Possible mechanisms of HAP detoxication in bacteria, yeast, and humans are considered.

(PDF emailed within 1 workday: $29.90)

Accession: 053380566

Download citation: RISBibTeXText

PMID: 19514135


Related references

Genetic control of metabolism of a mutagenic analog of 6-N-hydroxylaminopurine bases in Saccharomyces cerevisiae yeasts. Genetika 33(5): 591-598, 1997

Mutagenic specificity of the base analog 6-N-hydroxylaminopurine in the LYS2 gene of yeast Saccharomyces cerevisiae. Mutation Research 473(2): 151-161, 20 February, 2001

Mutagenic specificity of the base analog 6-N-hydroxylaminopurine in the URA3 gene of the yeast Saccharomyces cerevisiae. Mutagenesis 8(5): 417-421, 1993

Base analog 6-N-hydroxylaminopurine mutagenesis in the yeast Saccharomyces cerevisiae is controlled by replicative DNA polymerases. Mutation Research. 369(1-2): 33-44, 1996

Mutants of Saccharomyces cerevisiae supersensitive to the mutagenic effect of 6-N-hydroxylaminopurine. Genetika 22(9): 2235-2243, 1986

HAM1, the gene controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis in the yeast Saccharomyces cerevisiae. Yeast. 12(1): 17-29, 1996

Multiple antimutagenesis mechanisms affect mutagenic activity and specificity of the base analog 6-N-hydroxylaminopurine in bacteria and yeast. Mutation Research. 402(1-2): 41-50, E 18, 1998

Lys2 gene mutability in yeast saccharomyces cerevisiae of different ploidy ii. mutants induced by 6 n hydroxylaminopurine and propiolactone. Genetika 24: 1752-1760, 1988

Genetic analysis of spontaneous and 6-N-hydroxylaminopurine- and propiolactone-induced Adp+ mutants in Saccharomyces yeast. Soviet genetics 26(7): 761-767, 1991

Influence of the him1 mutation, characterized by increased induced mutagenesis, on the genetic effects of 6-N-hydroxylaminopurine in Saccharomyces cerevisiae. Soviet genetics 26(1): 20-24, 1990

The effect of mutation him1 characterized by enhanced induced mutagenesis on the genetic effects of 6-N-hydroxylaminopurine in Saccharomyces cerevisiae. Genetika 26(1): 30-36, 1990

Base analog N-6-hydroxylaminopurine mutagenesis in Escherichia coli: Genetic control and molecular specificity. Mutation Research 357(1-2): 1-15, 1996

Base analog 6-N-hydroxylaminopurine as a tool to study DNA replication mechanism in yeast. Journal of Cellular Biochemistry Supplement 0(21A): 302, 1995

LYS2 gene mutability in diploids of Saccharomyces yeast. II. Mutants indiced by 6-n-hydroxylaminopurine and propiolactone. Soviet genetics 24(10): 1219-1225, 1989

Hypersensitivity of Escherichia coli D(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis. Journal of Bacteriology 182(12): 61-7, 2000